Sumitomo Chemical India (SUMICHEM) Q1 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 24/25 earnings summary
5 Sep, 2025Executive summary
Achieved robust revenue growth of 16% year-over-year in Q1FY25, reaching ₹8,388.87 million, with strong recovery in the domestic market and improved market sentiment due to favorable monsoon forecasts and stable input costs.
EBITDA doubled to ₹161 crore, and PAT rose by 105% to ₹1,266.90 million, reflecting operational efficiency and margin improvement.
Launched multiple new products, including herbicides, insecticides, and fungicides, and intensified demand generation through the 'Every Day Farmers' Day' campaign, engaging over 283,000 stakeholders in 44 days.
Total comprehensive income for the quarter was ₹1,270.77 million, up from ₹614.98 million year-over-year.
Financial highlights
Q1FY25 revenue: ₹8,388.87 million (up 16% YoY); gross profit: ₹326.4 crore (up 45% YoY); gross margin: 38.9% (up 780 bps YoY).
EBITDA: ₹161.1 crore (up 100% YoY); EBITDA margin: 19.2% (up 807 bps YoY).
PAT: ₹1,266.90 million (up 105% YoY); PAT margin: 15.1% (up 659 bps YoY).
Net working capital days reduced to 60 from 94 YoY, with a release of ₹121 crore in working capital during the quarter.
Cash and cash equivalents as of June 30, 2024: ₹1,531 crore.
Outlook and guidance
Cautiously optimistic outlook for FY25, contingent on rainfall patterns in August and September; focus on recovering revenues lost in FY24 through demand generation and brand building.
Performance is seasonal and depends on monsoon and climatic conditions.
Ongoing initiatives and new product launches expected to drive medium- to long-term growth.
Latest events from Sumitomo Chemical India
- 9MFY26 revenue rose 5% with margin gains, but Q3 saw profit drop from one-time Labour Code charge.SUMICHEM
Q3 25/2630 Jan 2026 - Record H1 FY25 profit and margin growth driven by new products, exports, and strong demand outlook.SUMICHEM
Q2 24/2518 Jan 2026 - Double-digit growth, record margins, and strong outlook, amid regulatory and climate risks.SUMICHEM
Q4 24/257 Jan 2026 - H1 FY26 delivered 9% revenue growth, robust cash flow, and new launches despite Q2 headwinds.SUMICHEM
Q2 25/2628 Oct 2025 - Record Q1FY26 revenue and profit growth, with strong margins and ongoing regulatory risks.SUMICHEM
Q1 25/265 Sep 2025 - Q3FY25 saw robust revenue and profit growth, led by exports, with ongoing seasonal and regulatory risks.SUMICHEM
Q3 24/255 Sep 2025